YIH
SEEL

Y-Intercept (HK)’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Y-Intercept (HK)’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4
Closed -$11K – 1341
2022
Q2 		$11K Buy
+4
New +$10.4K ﹤0.01% 811

Other funds holding SEEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Y-Intercept (HK)'s SEEL Position: Q3 2022 in Review

Y-Intercept (HK) sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q3 2022, closing a stake of 4 shares — an estimated $11K sold.

Y-Intercept (HK) first reported a position in SEEL in Q2 2022 and held it in 1 quarter. The position peaked at $11K in Q2 2022. 68 funds tracked by Wall St. Rank hold SEEL as of Q3 2022.

  • Y-Intercept (HK) reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Y-Intercept (HK) sold 4 Seelos Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $11K.
  • Y-Intercept (HK) first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • Y-Intercept (HK)'s Seelos Therapeutics, Inc. Common Stock position peaked at $11K in Q2 2022.
  • 68 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Y-Intercept (HK)'s 13F filing for Q3 2022, filed 14 Feb 2023.